Kinase inhibition in autoimmunity and inflammation

Pattern Recognition Receptors and Inflammation

Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895

Apoptosis by Death Factor

Nagata, S. (1997) · Cell · doi:10.1016/s0092-8674(00)81874-7 · Cited by 4,934

Cell cycle, CDKs and cancer: a changing paradigm

Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957

Mechanisms of type-I- and type-II-interferon-mediated signalling

Platanias, L. C. (2005) · Nature reviews. Immunology · doi:10.1038/nri1604 · Cited by 3,631

The pro- and anti-inflammatory properties of the cytokine interleukin-6

Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212

Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced Macrophages

Hsieh, C.-S., Macatonia, S. E., Tripp, C. S., Wolf, S. F., O'Garra, A., & Murphy, K. M. (1993) · Science · doi:10.1126/science.8097338 · Cited by 3,134

Fcγ receptors as regulators of immune responses

Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2206 · Cited by 2,947

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906

Regulation and Function of NF-κB Transcription Factors in the Immune System

Vallabhapurapu, S., & Karin, M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132641 · Cited by 2,635

Acute respiratory distress syndrome

Matthay, M. A., Zemans, R. L., Zimmerman, G. A., Arabi, Y. M., Beitler, J. R., Mercat, A., Herridge, M. S., Randolph, A. G., & Calfee, C. S. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0069-0 · Cited by 2,514

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

Baechler, E. C., Batliwalla, F., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M. H., Kapur, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337679100 · Cited by 2,246

The non-canonical NF-κB pathway in immunity and inflammation

Sun, S. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.52 · Cited by 1,959

Mitogen-activated protein kinases in innate immunity

Arthur, J. S. C., & Ley, S. C. (2013) · Nature reviews. Immunology · doi:10.1038/nri3495 · Cited by 1,898

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

Richardson, P., Griffin, I., Tucker, C., Smith, D., Oechsle, O., Phelan, A., Rawling, M., Savory, E., & Stebbing, J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30304-4 · Cited by 1,456

p38 MAP-Kinases pathway regulation, function and role in human diseases

Cuenda, A., & Rousseau, S. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.03.010 · Cited by 1,450

The SYK tyrosine kinase: A crucial player in diverse biological functions

Mócsai, A., Ruland, J., & Tybulewicz, V. L. J. (2010) · Nature Reviews Immunology · doi:10.1038/nri2765 · Cited by 1,368

IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling

Kobayashi, K. S., Hernandez, L. D., Galán, J. E., Janeway, C. A., Medzhitov, R. M., & Flavell, R. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00827-9 · Cited by 1,310

TRAF6 is a signal transducer for interleukin-1

Cao, Z., Xiong, J., Takeuchi, M., Kurama, T., & Goeddel, D. V. (1996) · Nature · doi:10.1038/383443a0 · Cited by 1,305

Human autoimmune diseases: a comprehensive update

Wang, L., Wang, F., & Gershwin, M. E. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12395 · Cited by 1,274

JAK inhibition as a therapeutic strategy for immune and inflammatory diseases

Schwartz, D. M., Kanno, Y., Villarino, A., Ward, M., Gadina, M., & O'Shea, J. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.201 · Cited by 1,266

cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 Ubiquitination

Bertrand, M. J. M., Milutinovic, S., Dickson, K. M., Ho, W. C., Boudreault, A., Durkin, J. P., Gillard, J. W., Jaquith, J. B., Morris, S. J., & Barker, P. A. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.014 · Cited by 1,134

Helical Assembly in the MyD88-IRAK4-IRAK2 Complex in TLR/IL-1R Signalling

Lin, S.-C., Lo, Y.-C., & Wu, H. (2010) · Nature · doi:10.1038/nature09121 · Cited by 1,111

The Acute Respiratory Distress Syndrome: Pathogenesis and Treatment

Matthay, M. A., & Zemans, R. L. (2011) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130158 · Cited by 1,109

Transcriptional control of the inflammatory response

Medzhitov, R., & Horng, T. (2009) · Nature Reviews Immunology · doi:10.1038/nri2634 · Cited by 1,035

Kinase inhibitors: the road ahead

Ferguson, F. M., & Gray, N. S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.21 · Cited by 1,009

Tezepelumab in Adults with Uncontrolled Asthma

Corren, J., Parnes, J. R., Wang, L., Mo, M. F., Roseti, S. L., Griffiths, J. M., & van der Merwe, R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1704064 · Cited by 991

Resolution of inflammation: a new therapeutic frontier

Fullerton, J. N., & Gilroy, D. W. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.39 · Cited by 937

The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients

Treon, S. P., Castillo, J. J., Skarbnik, A. P. Z., Soumerai, J. D., Ghobrial, I. M., Guerrera, M. L., Meid, K., & Yang, G. (2020) · Blood · doi:10.1182/blood.2020006288 · Cited by 907

IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases

Teng, M. W. L., Bowman, E. P., McElwee, J. J., Smyth, M. J., Casanova, J., Cooper, A. M., & Cua, D. J. (2015) · Nature Medicine · doi:10.1038/nm.3895 · Cited by 905

NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease

Caruso, R., Warner, N., Inohara, N., & Núñez, G. (2014) · Immunity · doi:10.1016/j.immuni.2014.12.010 · Cited by 830

TNF-α Induction by LPS Is Regulated Posttranscriptionally via a Tpl2/ERK-Dependent Pathway

Dumitru, C. D., Ceci, J. D., Tsatsanis, C., Kontoyiannis, D. L., Stamatakis, K., Lin, J., Patriotis, C., Jenkins, N. A., Copeland, N. G., Kollias, G. A., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00210-5 · Cited by 810

Defective B cell development and function in Btk-deficient mice

Khan, W. N., Alt, F. W., Gerstein, R. M., Malynn, B. A., Larsson, I., Rathbun, G. A., Davidson, L., Müller, S., Kantor, A. B., Herzenberg, L. A., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90114-0 · Cited by 726

IRAK-4: A novel member of the IRAK family with the properties of an IRAK-kinase

Li, S., Strelow, A., Fontana, E. J., & Wesche, H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082100399 · Cited by 714

p38MAPK: stress responses from molecular mechanisms to therapeutics

Coulthard, L. R., White, D. E., Jones, D. L., McDermott, M. F., & Burchill, S. A. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.06.005 · Cited by 691

Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis

Newton, K., Dugger, D. L., Wickliffe, K. E., Kapoor, N., de Almagro, M. C., Vucic, D., Komuves, L., Ferrando, R. E., French, D. M., Webster, J., et al. (2014) · Science · doi:10.1126/science.1249361 · Cited by 687

Distinct molecular mechanism for initiating TRAF6 signalling

Ye, H., Arron, J. R., Lamothe, B., Cirilli, M., Kobayashi, T., Shevde, N. K., Segal, D., Dzivenu, O. K., Vologodskaia, M., Yim, M., et al. (2002) · Nature · doi:10.1038/nature00888 · Cited by 671

RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL

Lawlor, K. E., Khan, N. R., Mildenhall, A., Gerlic, M., Croker, B. A., D’Cruz, A. A., Hall, C. M., Spall, S. K., Anderton, H., Masters, S. L., et al. (2015) · Nature Communications · doi:10.1038/ncomms7282 · Cited by 660

Innate and Adaptive Immune Memory: an Evolutionary Continuum in the Host’s Response to Pathogens

Netea, M. G., Schlitzer, A., Placek, K., Joosten, L. A. B., & Schultze, J. L. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2018.12.006 · Cited by 644

RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity

Mandal, P., Berger, S. B., Pillay, S., Moriwaki, K., Huang, C., Guo, H., Lich, J. D., Finger, J. N., Kasparcova, V., Votta, B. J., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.10.021 · Cited by 634

Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk

Turner, M., Joseph Mee, P., Costello, P. S., Williams, O., Price, A. A., Duddy, L. P., Furlong, M. T., Geahlen, R. L., & Tybulewicz, V. L. J. (1995) · Nature · doi:10.1038/378298a0 · Cited by 612

Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK

Zarnegar, B. J., Wang, Y., Mahoney, D. J., Dempsey, P. W., Cheung, H. H., He, J., Shiba, T. L., Yang, X., Yeh, W., Mak, T. W., et al. (2008) · Nature Immunology · doi:10.1038/ni.1676 · Cited by 607

Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor

Changelian, P. S., Flanagan, M. E., Ball, D. J., Kent, C. R., Magnuson, K. S., Martin, W. H., Rizzuti, B. J., Sawyer, P. S., Perry, B. D., Brissette, W. H., et al. (2003) · Science · doi:10.1126/science.1087061 · Cited by 607

The Roles of Two IκB Kinase-related Kinases in Lipopolysaccharide and Double Stranded RNA Signaling and Viral Infection

Hemmi, H., Takeuchi, O., Sato, S., Yamamoto, M., Kaisho, T., Sanjo, H., Kawai, T., Hoshino, K., Takeda, K., & Akira, S. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040520 · Cited by 576

c-IAP1 and c-IAP2 Are Critical Mediators of Tumor Necrosis Factor α (TNFα)-induced NF-κB Activation

Varfolomeev, E. E., Goncharov, T., Fedorova, A. V., Dynek, J. N., Zobel, K., Deshayes, K., Fairbrother, W. J., & Vucic, D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800128200 · Cited by 572

Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis

Newton, K., Wickliffe, K. E., Dugger, D. L., Maltzman, A., Roose‐Girma, M., Dohse, M., Kömüves, L. G., Webster, J. D., & Dixit, V. M. (2019) · Nature · doi:10.1038/s41586-019-1548-x · Cited by 559

IFN-regulatory factor 3-dependent gene expression is defective in Tbk1 -deficient mouse embryonic fibroblasts

McWhirter, S. M., Fitzgerald, K. A., Rosains, J., Rowe, D. C., Golenbock, D. T., & Maniatis, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2237236100 · Cited by 542

The diverse role of RIP kinases in necroptosis and inflammation

Silke, J., Rickard, J. A., & Gerlic, M. (2015) · Nature Immunology · doi:10.1038/ni.3206 · Cited by 531

Syk tyrosine kinase required for mouse viability and B-cell development

Cheng, A. M., Rowley, B., Pao, W., Hayday, A., Bolen, J. B., & Pawson, T. (1995) · Nature · doi:10.1038/378303a0 · Cited by 528

R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation

Braselmann, S., Taylor, V., Zhao, H., Wang, S., Sylvain, C., Baluom, M., Qu, K., Herlaar, E., Lau, A., Young, C., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.109058 · Cited by 519

Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases

Harris, P. A., Berger, S. B., Jeong, J. U., Nagilla, R., Bandyopadhyay, D., Campobasso, N., Capriotti, C. A., Cox, J. A., Dare, L. C., Dong, X., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01751 · Cited by 504

Characterization of the Structure and Function of the Fourth Member of p38 Group Mitogen-activated Protein Kinases, p38δ

Jiang, Y., Gram, H., Zhao, M. F., New, L., Gu, J., Feng, L., Padova, F. D., Ulevitch, R. J., & Han, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30122 · Cited by 489

Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-α induction

Uematsu, S., Sato, S., Yamamoto, M., Hirotani, T., Kato, H., Takeshita, F., Matsuda, M., Coban, C., Ishii, K. J., Kawai, T., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042372 · Cited by 488

Phospholipase Cγ2 Is Essential in the Functions of B Cell and Several Fc Receptors

Wang, D., Feng, J., Wen, R., Marine, J.-C., Sangster, M. Y., Parganas, E., Hoffmeyer, A., Jackson, C. W., Cleveland, J. L., Murray, P. J., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00005-4 · Cited by 475

IRAK-M Is a Novel Member of the Pelle/Interleukin-1 Receptor-associated Kinase (IRAK) Family*

Wesche, H., Gao, X., Li, X.-X., Kirschning, C., Stark, G., & Cao, Z.-D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19403 · Cited by 475

Rip1 (Receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury

Linkermann, A., Bräsen, J. H., Himmerkus, N., Liu, S., Huber, T. B., Kunzendorf, U., & Krautwald, S. (2012) · Kidney International · doi:10.1038/ki.2011.450 · Cited by 462

RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury

Newton, K., Dugger, D. L., Maltzman, A., Greve, J. M., Hedehus, M., Martin-McNulty, B., Carano, R. A. D., Cao, T. C., van Bruggen, N., Bernstein, L., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.46 · Cited by 447

Sequential control of Toll-like receptor–dependent responses by IRAK1 and IRAK2

Kawagoe, T., Sato, S., Matsushita, K., Kato, H., Matsui, K., Kumagai, Y., Saitoh, T., Kawai, T., Takeuchi, O., & Akira, S. (2008) · Nature Immunology · doi:10.1038/ni.1606 · Cited by 443

Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact

Cantini, F., Niccoli, L., Matarrese, D., Nicastri, E., Stobbione, P., & Goletti, D. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.017 · Cited by 443

Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains

Emmerich, C. H., Ordureau, A., Strickson, S., Arthur, J. S. C., Pedrioli, P. G. A., Komander, D., & Cohen, P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314715110 · Cited by 442

An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice

Reilly, S. M., Chiang, S.-H., Decker, S. J., Chang, L. C., Uhm, M., Larsen, M. J., Rubin, J. R., Mowers, J. C., White, N. M. A., Hochberg, I., et al. (2013) · Nature Medicine · doi:10.1038/nm.3082 · Cited by 442

NF-κB-Independent Role of IKKα/IKKβ in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling

Dondelinger, Y., Jouan-Lanhouet, S., Divert, T., Theatre, E., Bertin, J., Gough, P. J., Giansanti, P., Heck, A. J. R., Dejardin, E., Vandenabeele, P., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.032 · Cited by 431

Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis

Papp, K. A., Gordon, K. B., Thaçi, D., Morita, A., Gooderham, M., Foley, P. A., Girgis, I. G., Kundu, S., & Banerjee, S. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1806382 · Cited by 426

Targeting RIPK1 for the treatment of human diseases

Degterev, A., Ofengeim, D., & Yuan, J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901179116 · Cited by 415

An Oligomeric Signaling Platform Formed by the Toll-like Receptor Signal Transducers MyD88 and IRAK-4

Motshwene, P. G., Moncrieffe, M. C., Grossmann, J. G., Kao, C. C., Murali, A., Sandercock, A. M., Robinson, C. V., Latz, E., & Gay, N. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.022392 · Cited by 403

Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B‐cell receptor activation

Fluckiger, A.-C., Li, Z., Kato, R. M., Wahl, M. I., Ochs, H. D., Longnecker, R., Kinet, J.-P., Witte, O. N., Scharenberg, A. M., & Rawlings, D. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.7.1973 · Cited by 399

The family of the interleukin‐1 receptors

Boraschi, D., Italiani, P., Weil, S., & Martin, M. U. (2017) · Immunological Reviews · doi:10.1111/imr.12606 · Cited by 399

The Ubiquitin Ligase XIAP Recruits LUBAC for NOD2 Signaling in Inflammation and Innate Immunity

Damgaard, R. B., Nachbur, U., Yabal, M., Wong, W. W.-L., Fiil, B. K., Kastirr, M., Rieser, E., Rickard, J. A., Bankovacki, A., Peschel, C., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.04.014 · Cited by 396

Modulation of Immune Complex–induced Inflammation In Vivo by the Coordinate Expression of Activation and Inhibitory Fc Receptors

Clynes, R., Maizes, J. S., Guinamard, R., Ono, M., Takai, T., & Ravetch, J. V. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.1.179 · Cited by 387

Ibrutinib treatment improves T cell number and function in CLL patients

Long, M., Beckwith, K. A., Do, P., Mundy-Bosse, B. L., Gordon, A. L., Lehman, A. M., Maddocks, K. J., Cheney, C. M., Jones, J. A., Flynn, J. M., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89756 · Cited by 387

An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis

Weinblatt, M. E., Kavanaugh, A., Genovese, M. C., Musser, T. K., Grossbard, E. B., & Magilavy, D. B. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000500 · Cited by 386

RIPK1 and RIPK3: critical regulators of inflammation and cell death

Newton, K. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.01.001 · Cited by 377

c‐IAP1 and UbcH5 promote K11‐linked polyubiquitination of RIP1 in TNF signalling

Dynek, J. N., Goncharov, T., Dueber, E. C., Fedorova, A. V., Izrael-Tomasevic, A., Phu, L., Helgason, E., Fairbrother, W. J., Deshayes, K., Kirkpatrick, D. S., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.300 · Cited by 369

Treatment of rheumatoid arthritis with a syk kinase inhibitor: A twelve‐week, randomized, placebo‐controlled trial

Weinblatt, M. E., Kavanaugh, A., Burgos‐Vargas, R., Dikranian, A. H., Medrano-Ramírez, G., Morales‐Torres, J., Murphy, F. T., Musser, T. K., Straniero, N., Vicente‐Gonzales, A. V., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23992 · Cited by 343

Multiple Functions of the IKK-Related Kinase IKKε in Interferon-Mediated Antiviral Immunity

tenOever, B. R., Ng, S., Chua, M. A., McWhirter, S. M., García‐Sastre, A., & Maniatis, T. (2007) · Science · doi:10.1126/science.1136567 · Cited by 342

Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis

Di Paolo, J. A., Huang, T., Balazs, M., Barbosa, J., Barck, K. H., Bravo, B. J., Carano, R. A. D., Darrow, J., Davies, D. R., DeForge, L. E., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.481 · Cited by 340

Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond

Karnell, J. L., Rieder, S. A., Ettinger, R., & Kolbeck, R. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.005 · Cited by 335

Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease

Lalaoui, N., Boyden, S. E., Oda, H., Wood, G., Stone, D. L., Chau, D., Liu, L., Stoffels, M., Kratina, T., Lawlor, K. E., et al. (2019) · Nature · doi:10.1038/s41586-019-1828-5 · Cited by 333

Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis

Geng, J., Ito, Y., Shi, L., Amin, P., Chu, J., Ouchida, A. T., Mookhtiar, A. K., Zhao, H., Xu, D., Shan, B., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00406-w · Cited by 325

Pirfenidone for Diabetic Nephropathy

Sharma, K., Ix, J. H., Mathew, A. V., Cho, M., Pflueger, A. C., Dunn, S., Francos, B. B., Sharma, S., Falkner, B. E., McGowan, T., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010101049 · Cited by 324

Placebo-controlled trial of an oral BTK inhibitor in multiple sclerosis

Montalban, X., Arnold, D. L., Weber, M. S., Staikov, I., Piasecka-Stryczynska, K., Willmer, J., Martin, E. C., Dangond, F., Syed, S., & Wolinsky, J. S. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1901981 · Cited by 324

Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution

Eyers, P. A., Craxton, M., Morricel, N., Cohen, P., & Goedert, M. (1998) · Chemistry & Biology · doi:10.1016/s1074-5521(98)90170-3 · Cited by 310

Evidence for licensing of IFN-γ-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program

Negishi, H., Fujita, Y., Yanai, H., Sakaguchi, S., Ouyang, X., Shinohara, M., Takayanagi, H., Ohba, Y., Taniguchi, T., & Honda, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607181103 · Cited by 310

Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain

Burke, J. R., Cheng, L., Gillooly, K. M., Strnad, J., Zupa-Fernandez, A., Catlett, I. M., Zhang, Y., Heimrich, E., McIntyre, K. W., Cunningham, M., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw1736 · Cited by 298

Autophagy protein ATG16L1 prevents necroptosis in the intestinal epithelium

Matsuzawa, Y., Shono, Y., Gomez, L. E., Hubbard-Lucey, V. M., Cammer, M., Neil, J. A., Dewan, M. Z., Lieberman, S. R., Lazrak, A., Marinis, J. M., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20170558 · Cited by 296

Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis

Mulay, S. R., Desai, J., Kumar, S. V. R., Eberhard, J. N., Thomasová, D., Romoli, S., Grigorescu, M., Kulkarni, O. P., Popper, B., Vielhauer, V., et al. (2016) · Nature Communications · doi:10.1038/ncomms10274 · Cited by 288

The functional plasticity of T cell subsets

Bluestone, J. A., Mackay, C. R., O’Shea, J. J., & Stockinger, B. (2009) · Nature reviews. Immunology · doi:10.1038/nri2654 · Cited by 286

Interleukin-1 (IL-1) Receptor-Associated Kinase-Dependent IL-1-Induced Signaling Complexes Phosphorylate TAK1 and TAB2 at the Plasma Membrane and Activate TAK1 in the Cytosol

Jiang, Z., Ninomiya‐Tsuji, J., Qian, Y., Matsumoto, K., & Li, X. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7158-7167.2002 · Cited by 284

Structural principles of tumor necrosis factor superfamily signaling

Vanamee, É. S., & Faustman, D. L. (2018) · Science Signaling · doi:10.1126/scisignal.aao4910 · Cited by 284

Impaired Cytokine Signaling in Mice Lacking the IL-1 Receptor-Associated Kinase

Thomas, J. A., Allen, J. L., Tsen, M. F., Dubnicoff, T., Danao, J., Liao, X. C., Cao, Z., & Wasserman, S. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.978 · Cited by 280

Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure

Hayashi, M., Kim, S.-W., Imanaka‐Yoshida, K., Yoshida, T., Abel, E. D., Eliceiri, B. P., Yang, Y. C., Ulevitch, R. J., & Lee, J.-D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19890 · Cited by 279

IL-1 Receptor-Associated Kinase Modulates Host Responsiveness to Endotoxin

Swantek, J. L., Tsen, M. F., Cobb, M. H., & Thomas, J. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4301 · Cited by 279

A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1

Tao, P., Sun, J., Wu, Z., Wang, S., Wang, J., Li, W., Pan, H., Bai, R., Zhang, J., Wang, Y., et al. (2019) · Nature · doi:10.1038/s41586-019-1830-y · Cited by 278

An open-label, phase II study of the safety and tolerability of pirfenidone in patients with scleroderma-associated interstitial lung disease: the LOTUSS trial

Khanna, D., Albera, C., Fischer, A., Khalidi, N., Raghu, G., Chung, L., Chen, D., Schiopu, E., Tagliaferri, M., Seibold, J. R., et al. (2016) · The Journal of Rheumatology · doi:10.3899/jrheum.151322 · Cited by 268

Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies

Cho, J. H., & Feldman, M. A. (2015) · Nature Medicine · doi:10.1038/nm.3897 · Cited by 267

ERK5 Is a Novel Type of Mitogen-Activated Protein Kinase Containing a Transcriptional Activation Domain

Kasler, H. G., Victoria, J. G., Duramad, O., & Winoto, A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8382-8389.2000 · Cited by 267

Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity

Dendrou, C. A., Cortes, A., Shipman, L., Evans, H. G., Attfield, K. E., Jostins, L., Barber, T., Kaur, G., Kuttikkatte, S. B., Leach, O. A., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aag1974 · Cited by 264

Involvement of Bruton's Tyrosine Kinase in FcεRI-dependent Mast Cell Degranulation and Cytokine Production

Hata, D., Kawakami, Y., Inagaki, N., Lantz, C. S., Kitamura, T., Khan, W. N., Maeda‐Yamamoto, M., Miura, T., Han, W., Hartman, S. E., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1235 · Cited by 262

Intracellular regulation of TNF activity in health and disease

Varfolomeev, E. E., & Vucic, D. (2016) · Cytokine · doi:10.1016/j.cyto.2016.08.035 · Cited by 257

ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia

Chen, L., Apgar, J. R., Huynh, L., Dicker, F., Giago-McGahan, T., Rassenti, L. Z., Weiss, A., & Kipps, T. J. (2004) · Blood · doi:10.1182/blood-2004-05-1715 · Cited by 248

Regulation of PKD by the MAPK p38δ in Insulin Secretion and Glucose Homeostasis

Sumara, G., Formentini, I., Collins, S. C., Sumara, I., Windak, R., Bodenmiller, B., Ramracheya, R. D., Caille, D., Jiang, H., Platt, K. A., et al. (2009) · Cell · doi:10.1016/j.cell.2008.11.018 · Cited by 244

Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure

Hayashi, M., Kim, S.-W., Imanaka‐Yoshida, K., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419890 · Cited by 241

Structural Basis for the Inhibition of Tyrosine Kinase Activity of ZAP-70

Deindl, S., Kadlecek, T. A., Brdička, T., Cao, X., Weiss, A., & Kuriyan, J. (2007) · Cell · doi:10.1016/j.cell.2007.03.039 · Cited by 240

Getting Syk: spleen tyrosine kinase as a therapeutic target

Geahlen, R. L. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.05.007 · Cited by 240

Innate immune recognition of DNA: A recent history

Dempsey, A., & Bowie, A. (2015) · Virology · doi:10.1016/j.virol.2015.03.013 · Cited by 229

Acquisition of Sensitivity of Stress-activated Protein Kinases to the p38 Inhibitor, SB 203580, by Alteration of One or More Amino Acids within the ATP Binding Pocket

Gum, R. J., McLaughlin, M. M., Kumar, S., Wang, Z., Bower, M. J., Lee, J. C., Adams, J. L., Livi, G. P., Goldsmith, E. J., & Young, P. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15605 · Cited by 229

ERK5: Structure, regulation and function

Nithianandarajah-Jones, G. N., Wilm, B., Goldring, C. E., Müller, J., & Cross, M. J. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.07.007 · Cited by 226

A conserved Mediator–CDK8 kinase module association regulates Mediator–RNA polymerase II interaction

Tsai, K.-L., Sato, S., Tomomori-Sato, C., Conaway, R. C., Conaway, J. W., & Asturias, F. J. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2549 · Cited by 219

IL-13–induced airway mucus production is attenuated by MAPK13 inhibition

Alevy, Y. G., Patel, A. C., Romero, A. G., Patel, D. A., Tucker, J., Roswit, W. T., Miller, C. A., Heier, R. F., Byers, D. E., Brett, T. J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64896 · Cited by 218

Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon Fc epsilon RI cross-linking.

Kawakami, Y., Yao, L., Miura, T., Tsukada, S., Witte, O. N., & Kawakami, T. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5108 · Cited by 213

Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor

Pine, P. R., Chang, B. Y., Schoettler, N., Banquerigo, M. L., Wang, S., Lau, A., Zhao, F., Grossbard, E. B., Payan, D. G., & Brahn, E. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.03.543 · Cited by 209

The secret life of kinases: functions beyond catalysis

Rauch, J., Volinsky, N., Romano, D., & Kölch, W. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-23 · Cited by 209

NF-κB1/p105 Regulates Lipopolysaccharide-Stimulated MAP Kinase Signaling by Governing the Stability and Function of the Tpl2 Kinase

Waterfield, M. R., Zhang, M., Norman, L. P., & Sun, S. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00070-4 · Cited by 209

Human TBK1: A Gatekeeper of Neuroinflammation

Ahmad, L., Zhang, S.-Y., Casanova, J.-L., & Sancho-Shimizu, V. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.04.006 · Cited by 208

Targeting protein kinases for the development of anti-inflammatory drugs

Cohen, P. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.01.015 · Cited by 207

Lipopolysaccharide Activation of the TPL-2/MEK/Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase Cascade Is Regulated by IκB Kinase-Induced Proteolysis of NF-κB1 p105

Beinke, S., Robinson, M. J., Hugunin, M., & Ley, S. C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9658-9667.2004 · Cited by 205

Immunological memory: lessons from the past and a look to the future

Farber, D. L., Netea, M. G., Radbruch, A., Rajewsky, K., & Zinkernagel, R. M. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.13 · Cited by 200

Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases

Patterson, H., Nibbs, R., McInnes, I., & Siebert, S. (2014) · Clinical and Experimental Immunology · doi:10.1111/cei.12248 · Cited by 199

Ability of Bruton’s Tyrosine Kinase Inhibitors to Sequester Y551 and Prevent Phosphorylation Determines Potency for Inhibition of Fc Receptor but not B-Cell Receptor Signaling

Bender, A. T., Gardberg, A. S., Pereira, A., Johnson, T. L., Wu, Y., Grenningloh, R., Head, J. C., Morandi, F., Haselmayer, P., & Liu‐Bujalski, L. (2017) · Molecular Pharmacology · doi:10.1124/mol.116.107037 · Cited by 198

An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia

Sharman, J. P., Hawkins, M., Kolibaba, K. S., Boxer, M. A., Klein, L. M., Wu, M., Hu, J., Abella, S., & Yasenchak, C. A. (2015) · Blood · doi:10.1182/blood-2014-08-595934 · Cited by 197

Systemic autoinflammatory diseases

Krainer, J., Siebenhandl, S., & Weinhäusel, A. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102421 · Cited by 194

The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation

Bulek, K., Liu, C., Swaidani, S., Wang, L., Page, R. C., Gulen, M. F., Herjan, T., Abbadi, A., Qian, W., Sun, D., et al. (2011) · Nature Immunology · doi:10.1038/ni.2080 · Cited by 192

Function of CSF1 and IL34 in Macrophage Homeostasis, Inflammation, and Cancer

Lin, W., Xu, D., Austin, C. D., Caplazi, P., Senger, K., Sun, Y., Jeet, S., Young, J., Delarosa, D., Suto, E., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02019 · Cited by 192

Requirement of phospholipase C-gamma 2 activation in surface immunoglobulin M-induced B cell apoptosis.

Takata, M., Homma, Y., & Kurosaki, T. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.4.907 · Cited by 191

Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor–mediated immune responses but not in TCR signaling

Kawagoe, T., Sato, S., Jung, A., Yamamoto, M., Matsui, K., Kato, H., Uematsu, S., Takeuchi, O., & Akira, S. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061523 · Cited by 187

Oral p38 Mitogen-Activated Protein Kinase Inhibition With BIRB 796 for Active Crohn’s Disease: A Randomized, Double-Blind, Placebo-Controlled Trial

Schreiber, S., Feagan, B. G., D’Haens, G., Colombel, J., Geboes, K. J., Yurcov, M., Va, I., Головенко, О. В., Bernstein, C. N., Ludwig, D., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.11.013 · Cited by 186

Artificial Intelligence in Drug Discovery

Sellwood, M. A., Ahmed, M., Segler, M., & Brown, N. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0212 · Cited by 186

Structural basis for p38α MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity

Fitzgerald, C. E., Patel, S. B., Becker, J. W., Cameron, P. M., Zaller, D. M., Pikounis, V. B., O’Keefe, S. J., & Scapin, G. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb949 · Cited by 182

Regulatory T cells in skin injury: At the crossroads of tolerance and tissue repair

Boothby, I. C., Cohen, J. N., & Rosenblum, M. D. (2020) · Science Immunology · doi:10.1126/sciimmunol.aaz9631 · Cited by 182

Structural Basis for the Non-catalytic Functions of Protein Kinases

Kung, J. E., & Jura, N. (2016) · Structure · doi:10.1016/j.str.2015.10.020 · Cited by 180

Experimental and natural infections in M y D 88‐ and IRAK ‐4‐deficient mice and humans

von Bernuth, H., Pïcard, C., Puel, A., & Casanova, J. (2012) · European Journal of Immunology · doi:10.1002/eji.201242683 · Cited by 178

Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities

Porter, D. C., Farmaki, E., Altilia, S., Schools, G. P., West, D. K., Chen, M., Chang, B.-D., Puzyrev, A. T., Lim, C., Rokow-Kittell, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206906109 · Cited by 177

Discovery of GS-9973, a Selective and Orally Efficacious Inhibitor of Spleen Tyrosine Kinase

Currie, K., Kropf, J. E., Lee, T., Blomgren, P., Xu, J., Zhao, Z., Gallion, S., Whitney, J. A., Maclin, D., Lansdon, E. B., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500228a · Cited by 175

Cbl-mediated Negative Regulation of the Syk Tyrosine Kinase

Lupher, M., Rao, N. L., Lill, N. L., Andoniou, C. E., Miyake, S., Clark, E. A., Druker, B. J., & Band, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.35273 · Cited by 172

JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders

Vainchenker, W., Leroy, E., Gilles, L., Marty, C., Plo, I., & Constantinescu, S. N. (2018) · F1000Research · doi:10.12688/f1000research.13167.1 · Cited by 167

TEC-family kinases: regulators of T-helper-cell differentiation

Schwartzberg, P. L., Finkelstein, L. D., & Readinger, J. A. (2005) · Nature reviews. Immunology · doi:10.1038/nri1591 · Cited by 165

PF-06651600, a Dual JAK3/TEC Family Kinase Inhibitor

Xu, H., Jesson, M. I., Seneviratne, U. I., Lin, T. H., Sharif, M., Xue, L., Nguyen, C., Everley, R. A., Trujillo, J. I., Johnson, D. S., et al. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00188 · Cited by 165

Inhibition of keratinocyte necroptosis mediated by RIPK1/RIPK3/MLKL provides a protective effect against psoriatic inflammation

Duan, X., Liu, X., Liu, N., Huang, Y., Jin, Z., Zhang, S., Ming, Z., & Chen, H. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2328-0 · Cited by 163

IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts

Kopp, E. B. (2004) · Medical Entomology and Zoology · Cited by 160

The Other Function: Class II-Restricted Antigen Presentation by B Cells

Adler, L. N., Jiang, W., Bhamidipati, K., Millican, M., Macaubas, C., Hung, S.-C., & Mellins, E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00319 · Cited by 159

Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity

Willmann, K. L., Klaver, S., Doğu, F., Santos-Valente, E., Garncarz, W., Bilić, I., Mace, E. M., Salzer, E., Conde, C. D., Sic, H., et al. (2014) · Nature Communications · doi:10.1038/ncomms6360 · Cited by 157

Molecular Cloning of Mouse ERK5/BMK1 Splice Variants and Characterization of ERK5 Functional Domains

Chen, Y., Luo, H., Lee, J.-D., Abe, J., & Berk, B. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009286200 · Cited by 156

Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease

Caso, F., Galozzi, P., Costa, L., Sfriso, P., Cantarini, L., & Punzi, L. (2015) · RMD Open · doi:10.1136/rmdopen-2015-000097 · Cited by 156

Interleukin-1 receptor–associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling

Nardo, D. D., Balka, K. R., Gloria, Y. C., Rao, V. R., Latz, E., & Masters, S. L. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003314 · Cited by 156

Differential activation of p38MAPK isoforms by MKK6 and MKK3

Rémy, G., Risco, A. M., Iñesta-Vaquera, F., González‐Terán, B., Sabio, G., Davis, R. J., & Cuenda, A. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.11.020 · Cited by 155

The Novel JAK-3 Inhibitor CP-690550 Is a Potent Immunosuppressive Agent in Various Murine Models

Kudlacz, E. M., Perry, B. D., Sawyer, P. S., Conklyn, M. J., McCurdy, S. P., Brissette, W. H., and, M. F., & Changelian, P. S. (2003) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2003.00281.x · Cited by 154

RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases

Patel, S. D., Webster, J. D., Varfolomeev, E. E., Kwon, Y. C., Cheng, J. H., Zhang, J., Dugger, D. L., Wickliffe, K. E., Maltzman, A., Sujatha-Bhaskar, S., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0347-0 · Cited by 152

Conversion of antigen-specific effector/memory T cells into Foxp3-expressing T reg cells by inhibition of CDK8/19

Akamatsu, M., Mikami, N., Ohkura, N., Kawakami, R., Kitagawa, Y., Sugimoto, A., Hirota, K., Nakamura, N., Ujihara, S., Kurosaki, T., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aaw2707 · Cited by 148

IRAK4 Dimerization and trans -Autophosphorylation Are Induced by Myddosome Assembly

Ferrao, R., Zhou, H., Shan, Y., Liu, Q., Li, Q., Shaw, D. E., Li, X., & Wu, H. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.006 · Cited by 147

IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease

Ku, C., Pïcard, C., Erdös, M., Jeurissen, A., Bustamante, J. C., Puel, A., von Bernuth, H., Filipe‐Santos, O., Chang, H., Lawrence, T., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.044446 · Cited by 144

Immune Checkpoints as Therapeutic Targets in Autoimmunity

Paluch, C., Santos, A. M., Anzilotti, C., Cornall, R. J., & Davis, S. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02306 · Cited by 142

Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL

Barr, P. M., Saylors, G. B., Spurgeon, S. E. F., Cheson, B. D., Greenwald, D. R., O'Brien, S. M., Liem, A. K. D., Mclntyre, R. E., Joshi, A., Abella-Dominicis, E., et al. (2016) · Blood · doi:10.1182/blood-2015-12-683516 · Cited by 141

Tpl2/Cot Signals Activate ERK, JNK, and NF-κB in a Cell-type and Stimulus-specific Manner

Das, S., Cho, J., Lambertz, I., Kelliher, M. A., Eliopoulos, A. G., Du, K., & Tsichlis, P. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412837200 · Cited by 138

Tec Family Kinases Modulate Thresholds for Thymocyte Development and Selection

Schaeffer, E. M., Broussard, C., Debnath, J., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.987 · Cited by 137

IRAK‐M mediates Toll‐like receptor/IL‐1R‐induced NFκB activation and cytokine production

Zhou, H., Yu, M., Fukuda, K., Im, J., Yao, P., Cui, W., Bulek, K., Zepp, J. A., Wan, Y., Kim, T. W., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.2 · Cited by 136

AP-2-Associated Protein Kinase 1 and Cyclin G-Associated Kinase Regulate Hepatitis C Virus Entry and Are Potential Drug Targets

Neveu, G., Ziv-Av, A., Barouch‐Bentov, R., Berkerman, E., Mulholland, J., & Einav, S. (2015) · Journal of Virology · doi:10.1128/jvi.02705-14 · Cited by 135

Interferon‐regulatory‐factor 1 controls Toll‐like receptor 9‐mediated IFN‐β production in myeloid dendritic cells

Schmitz, F., Heit, A., Guggemoos, S., Krug, A., Mages, J., Schiemann, M., Adler, H., Drexler, I., Haas, T. L., Lang, R., et al. (2007) · European Journal of Immunology · doi:10.1002/eji.200636767 · Cited by 134

TPL2-mediated activation of ERK1 and ERK2 regulates the processing of pre-TNFα in LPS-stimulated macrophages

Rousseau, S., Papoutsopoulou, M., Symons, A., Cook, D., Lucocq, J. M., Prescott, A. R., O’Garra, A., Ley, S. C., & Cohen, P. (2008) · Journal of Cell Science · doi:10.1242/jcs.018671 · Cited by 134

Type I interferonopathies in pediatric rheumatology

Volpi, S., Picco, P. P., Caorsi, R., Candotti, F., & Gattorno, M. (2016) · Pediatric Rheumatology · doi:10.1186/s12969-016-0094-4 · Cited by 134

Diverse ubiquitin linkages regulate RIP kinases-mediated inflammatory and cell death signaling

Witt, A., & Vucic, D. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.33 · Cited by 133

NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus

Brightbill, H. D., Suto, E., Blaquière, N., Ramamoorthi, N., Sujatha-Bhaskar, S., Gogol, E. B., Castanedo, G. M., Jackson, B. T., Kwon, Y. C., Haller, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02672-0 · Cited by 132

p38γ and p38δ kinases regulate the Toll-like receptor 4 (TLR4)-induced cytokine production by controlling ERK1/2 protein kinase pathway activation

Risco, A., del Fresno, C., Mambol, A., Alsina‐Beauchamp, D., MacKenzie, K. F., Yang, H., Barber, D. F., Morcelle, C., Arthur, J. S. C., Ley, S. C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207290109 · Cited by 130

Disruption of XIAP-RIP2 Association Blocks NOD2-Mediated Inflammatory Signaling

Goncharov, T., Hedayati, S., Mulvihill, M. M., Izrael-Tomasevic, A., Zobel, K., Jeet, S., Fedorova, A. V., Eidenschenk, C., DeVoss, J., Yu, K., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.016 · Cited by 127

Coordinated ubiquitination and phosphorylation of RIP1 regulates necroptotic cell death

de Almagro, M. C., Goncharov, T., Izrael-Tomasevic, A., Duttler, S., Kist, M., Varfolomeev, E. E., Wu, X., Lee, W. P., Murray, J. M., Webster, J. D., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.78 · Cited by 125

NF-κB1 p105 Negatively Regulates TPL-2 MEK Kinase Activity

Beinke, S., Deka, J., Lang, V., Belich, M. P., Walker, P. A., Howell, S. A., Smerdon, S. J., Gamblin, S. J., & Ley, S. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.14.4739-4752.2003 · Cited by 124

Structure-Based Optimization of Potent, Selective, and Orally Bioavailable CDK8 Inhibitors Discovered by High-Throughput Screening

Czodrowski, P., Mallinger, A., Wienke, D., Esdar, C., Pöschke, O., Busch, M., Rohdich, F., Eccles, S. A., Ortiz-Ruiz, M.-J., Schneider, R., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00597 · Cited by 123

Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton’s Tyrosine Kinase (BTK)

Watterson, S. H., Liu, Q., Bertrand, M. B., Batt, D. G., Li, L., Pattoli, M. A., Skala, S., Cheng, L., Obermeier, M. T., Moore, R., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00167 · Cited by 120

Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation

Yu, J., Zhou, X., Chang, M., Nakaya, M., Chang, J.-H., Xiao, Y., William Lindsey, J., Dorta-Estremera, S., Cao, W., Zal, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms7074 · Cited by 118

The Unique C-terminal Tail of the Mitogen-activated Protein Kinase ERK5 Regulates Its Activation and Nuclear Shuttling

Buschbeck, M., & Ullrich, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412599200 · Cited by 118

Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Modulators of the Mediator Complex-Associated Kinases CDK8 and CDK19

Mallinger, A., Schiemann, K., Rink, C., Stieber, F., Calderini, M., Crumpler, S., Stubbs, M., Adeniji-Popoola, O., Poeschke, O., Busch, M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01685 · Cited by 117

Genetic deficiency of Syk protects mice from autoantibody‐induced arthritis

Jakus, Z., Simon, E., Balázs, B., & Mócsai, A. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27438 · Cited by 115

Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis

Coffey, G., DeGuzman, F. R., Inagaki, M., Pak, Y., Delaney, S. M., Ives, D. J., Betz, A., Jia, Z. J., Pandey, A., Baker, D. C., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.188441 · Cited by 114

Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility

Couturier, N., Bucciarelli, F., Nurtdinov, R., Debouverie, M., Lebrun‐Frénay, C., Defer, G. L., Moreau, T., Confavreux, C., Vukusic, S., Cournu‐Rebeix, I., et al. (2011) · Brain · doi:10.1093/brain/awr010 · Cited by 112

The Dietary Flavonoid Kaempferol Mediates Anti‐Inflammatory Responses via the Src, Syk, IRAK1, and IRAK4 Molecular Targets

Kim, S. H., Park, J. G., Lee, J., Yang, W. S., Park, K. W., Kim, H. G., Yi, Y., Baek, K., Sung, N. Y., Hossen, M. J., et al. (2015) · Mediators of Inflammation · doi:10.1155/2015/904142 · Cited by 109

Multitasking Kinase RIPK1 Regulates Cell Death and InflammationPreprint

Newton, K. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a036368 · Cited by 107

New directions in the basic and translational biology of interleukin-27

Wojno, E. D. T., & Hunter, C. A. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.11.003 · Cited by 106

Cortistatin A is a High‐Affinity Ligand of Protein Kinases ROCK, CDK8, and CDK11

Cee, V. J., Chen, D. Y. ‐., Lee, M. R., & Nicolaou, K. C. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200904778 · Cited by 105

Eukaryotic elongation factor 2 controls TNF-α translation in LPS-induced hepatitis

González‐Terán, B., Cortés, J. R., Manieri, E., Matesanz, N., Verdugo, Á., Rodríguez, M. E., González‐Rodríguez, Á., Valverde, Á. M., Martı́n, P., Davis, R. J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci65124 · Cited by 104

Selective inhibition of the p38α MAPK–MK2 axis inhibits inflammatory cues including inflammasome priming signals

Wang, C., Hockerman, S. L., Jacobsen, E. J., Alippe, Y., Selness, S. R., Hope, H. R., Hirsch, J. L., Mnich, S. J., Saabye, M. J., Hood, W. F., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20172063 · Cited by 103

In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib

Rolf, M. G., Curwen, J., Veldman-Jones, M. H., Eberlein, C., Wang, J., Harmer, A., Hellawell, C. J., & Braddock, M. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.175 · Cited by 102

Review of Bruton Tyrosine Kinase Inhibitors for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Owen, C., Berinstein, N. L., Christofides, A., & Sehn, L. H. (2019) · Current Oncology · doi:10.3747/co.26.4345 · Cited by 101

HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19

Spinelli, F. R., Conti, F., & Gadina, M. (2020) · Science Immunology · doi:10.1126/sciimmunol.abc5367 · Cited by 101

ERK5 kinase activity is dispensable for cellular immune response and proliferation

Lin, E. C. K., Amantea, C. M., Nomanbhoy, T. K., Weissig, H., Ishiyama, J., Hu, Y., Sidique, S., Li, B., Kozarich, J. W., & Rosenblum, J. S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609019113 · Cited by 99

The JAK-3 inhibitor CP-690550 is a potent anti-inflammatory agent in a murine model of pulmonary eosinophilia

Kudlacz, E. M., Conklyn, M. J., Andresen, C. J., et al. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.12.024 · Cited by 97

Regulation of PTEN activity by p38δ-PKD1 signaling in neutrophils confers inflammatory responses in the lung

Ittner, A., Block, H., Reichel, C. A., Varjosalo, M. T., Gehart, H., Sumara, G., Gstaiger, M., Krombach, F., Zarbock, A., & Ricci, R. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20120677 · Cited by 97

Repurposing of Kinase Inhibitors as Broad-Spectrum Antiviral Drugs

Schor, S., & Einav, S. (2017) · DNA and Cell Biology · doi:10.1089/dna.2017.4033 · Cited by 97

Recent advances in colony stimulating factor-1 receptor/c-FMS as an emerging target for various therapeutic implications

Kumari, A., Silakari, O., & Singh, R. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.046 · Cited by 97

ABIN-2 Forms a Ternary Complex with TPL-2 and NF-κB1 p105 and Is Essential for TPL-2 Protein Stability

Lang, V., Symons, A., Watton, S. J., Janzen, J., Soneji, Y., Beinke, S., Howell, S. A., & Ley, S. C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5235-5248.2004 · Cited by 95

Intestinal myofibroblast-specific Tpl2-Cox-2-PGE 2 pathway links innate sensing to epithelial homeostasis

Roulis, M., Nikolaou, C., Kotsaki, E., Kaffe, E., Karagianni, N., Koliaraki, V., Salpea, K. D., Ragoussis, J., Aidinis, V., Martini, E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415762111 · Cited by 94

IRAK-4 Kinase Activity Is Required for Interleukin-1 (IL-1) Receptor- and Toll-like Receptor 7-mediated Signaling and Gene Expression

Koziczak‐Holbro, M., Joyce, C., Glück, A., Kinzel, B., Müller, M., Tschopp, C., Mathison, J. C., Davis, C. N., & Gram, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700548200 · Cited by 92

Fostamatinib: First Global Approval

Markham, A. (2018) · Drugs · doi:10.1007/s40265-018-0927-1 · Cited by 92

Development of Gut-Selective Pan-Janus Kinase Inhibitor TD-1473 for Ulcerative Colitis: A Translational Medicine Programme

Sandborn, W. J., Nguyen, D. D., Beattie, D. T., Brassil, P. J., Krey, W., Woo, J., Situ, E., Sana, R., Sandvik, E., Pulido-Rios, M. T., et al. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa049 · Cited by 92

Two Phases of Inflammatory Mediator Production Defined by the Study of IRAK2 and IRAK1 Knock-in Mice

Pauls, E., Nanda, S. K., Smith, H., Toth, R. L., Arthur, J. S. C., & Cohen, P. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203268 · Cited by 91

Patient Perceptions of Unmet Medical Need in Rheumatoid Arthritis: A Cross-Sectional Survey in the USA

Radawski, C., Genovese, M. C., Hauber, B., et al. (2019) · Rheumatology and Therapy · doi:10.1007/s40744-019-00168-5 · Cited by 90

Interleukin-1 Receptor-associated Kinase 2 Is Critical for Lipopolysaccharide-mediated Post-transcriptional Control

Wan, Y., Xiao, H. Q., Affolter, J. T., Kim, T. W., Bulek, K., Chaudhuri, S., Carlson, D., Hamilton, T. A., Mazumder, B., Stark, G. R., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807822200 · Cited by 89

Structural and Biophysical Characterization of the Syk Activation Switch

Grädler, U., Schwarz, D. F., Dresing, V., Müsil, D., Bomke, J., Frech, M., Greiner, H. E., Jäkel, S., Rysiok, T., Müller-Pompalla, D., et al. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.11.007 · Cited by 86

A new family of IKK-related kinases may function as IκB kinase kinases

Peters, R., & Maniatis, T. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00024-x · Cited by 85

Syk Activation and Dissociation from the B-cell Antigen Receptor Is Mediated by Phosphorylation of Tyrosine 130

Keshvara, L. M., Isaacson, C., Harrison, M. L., & Geahlen, R. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10377 · Cited by 83

Therapeutic potential of targeting TBK1 in autoimmune diseases and interferonopathies

Hasan, M., & Yan, N. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.04.008 · Cited by 83

Comprehensive RNAi-based screening of human and mouse TLR pathways identifies species-specific preferences in signaling protein use

Sun, J., Li, N., Oh, K., Dutta, B., Vayttaden, S. J., Lin, B., Ebert, T. S., Nardo, D. D., Davis, J., Bagirzadeh, R., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aab2191 · Cited by 81

Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy

Margaritopoulos, G. A., Vasarmidi, E., & Antoniou, K. M. (2016) · Core evidence · doi:10.2147/ce.s76549 · Cited by 81

PROTAC targeted protein degraders: the past is prologue

Békés, M., Langley, D. R., & Crews, C. M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00371-6 · Cited by 3,395

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

Ahern, D. J., Ai, Z., Ainsworth, M., Allan, C., Allcock, A., Angus, B., Ansari, M. A., Arancibia-Cárcamo, C. V., Aschenbrenner, D., Attar, M., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.012 · Cited by 328

BLNK mediates Syk-dependent Btk activation

Baba, Y., Hashimoto, S., Matsushita, M., Watanabe, D., Kishimoto, T., Kurosaki, T., & Tsukada, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051626198 · Cited by 148

Differential Regulation of GPVI-Induced Btk and Syk Activation by PKC, PKA and PP2A in Human Platelets

Zhang, P., Solari, F. A., Heemskerk, J. W. M., Kuijpers, M. J. E., Sickmann, A., Walter, U., & Jurk, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097776 · Cited by 10

Development of a Pharmacodynamic Assay Based on PLCγ2 Phosphorylation for Quantifying Spleen Tyrosine Kinase (SYK)–Bruton’s Tyrosine Kinase (BTK) Signaling

Hsu, J., Zhang, J., Kitson, C., et al. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113489881 · Cited by 2

Tyrosine Kinase Inhibitors (TKIs) Targeting Syk and BTK Signaling Differentially Affect PI3K Signalosome Organization and Platelet Function

Zheng, T. J., Lofurno, E. R., Elgamal, S., et al. (2019) · Blood · doi:10.1182/blood-2019-129066 · Cited by 1

Potential applications of Bruton’s tyrosine kinase inhibitors for the prevention of allergic reactions

Dispenza, M. C., Regan, J. A., & Bochner, B. S. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1370374 · Cited by 22